Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Vibrio cholerae O1 Ogawa and Inaba lipopolysaccharide (LPS) antigen** is a major surface polysaccharide of *Vibrio cholerae* O1, the dominant cause of cholera epidemics[1][5][9]. Its structure consists of lipid A, a core oligosaccharide, and a repeating O-specific polysaccharide (O-SP). The Ogawa and Inaba serotypes differ by a single chemical modification: the Ogawa serotype's terminal perosamine unit is 2-O-methylated, while the Inaba terminal perosamine has a hydroxyl group at that position[1][3][5][9]. This small difference results in distinct antigenic properties, which dictate serotype-specific immune recognition and are targets for vibriocidal antibodies after infection or vaccination[5][9]. Anti-LPS antibodies are strong correlates of cholera protection, making these antigens central to subunit vaccine and monoclonal antibody development[5][1]. Because LPS is also an endotoxin, there are potential concerns about reactogenicity if large doses are administered, but in the context of natural infection and vaccination, these antigens are essential mediators of both disease and protective immunity[1][5].
Induction of protective antibody responses (by immune system or vaccine); Antibody-mediated neutralization
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 Ogawa and Inaba lipopolysaccharide antigen (null).